EUROPEAN RENAL CARE PROVIDERS ASSOCIATION
Founded in early 2014, our association raises awareness of the situation of patients suffering from chronic kidney disease or related chronic diseases by ensuring access to safe, effective and personalised care of the highest quality, promoting choice in treatment modality, and educating policy makers on critical healthcare legislation.
OUR VISION
A European Union where patients affected by chronic renal disease or related chronic diseases are guaranteed access to safe, effective, and personalised care of the highest quality.
OUR VALUES
Patient Choice
Care Excellence
Outcome Transparency
Sustainable Systems
OUR MISSION
We partner with policy makers and civil society to discuss, inform and educate on effective and efficient chronic disease management.
We support effective and efficient EU healthcare legislation on chronic diseases with a particular focus on patients affected by the renal disease.
We promote transparency of treatment outcomes in order to support continuous improvement of the quality of patient care.
We increase the focus on prevention and ensure a patient’s right to choose his or her most suitable treatment modality.
CHRONIC KIDNEY DISEASE – WHY DOES IT MATTER ?
Chronic kidney disease, also called chronic renal disease (CRD), is a progressive loss of kidney function which, if left untreated by transplant or ongoing renal replacement therapy like dialysis, will lead to death. CKD is a lifelong disease affecting more than 3 million people globally, with this total increasing every year.
Individuals living with CKD describe the need to adjust to a “new normal” which can include food and fluid restrictions, complex medication management, and lengthy dialysis treatments as part of their daily lives. The ability to choose a suitable treatment modality, the care of a dedicated clinical team, and a high-quality treatment are critical to ensuring quality of life for these patients.
Read more in our Manifesto for a patient-centric management of CKD.
SOME FIGURES
Number of EU inhabitants who have CKD stages 3-5
Length of a haemodialysis session
Annual cost of one stage 5 patient (total or near-total loss of kidney function)
Most don’t know it. CKD has no symptoms until the most advanced stages.
Patients usually undergo 3 sessions per week.
Dialysis alone costs €14 billion per year to EU health systems.
ERCPA asbl
Rue du Noyer 183
1000 Brussels
Belgium
Tel : +32 (0)2 240 27 12
Email : secretariat (at) ercpa.eu
Other helpful websites and publications